ASCO microfluidic valves can shorten product development cycles

Home > Pumps & Valves > ASCO microfluidic valves can shorten product development cycles

9th May 2018

Source: Emerson Industrial Automation, Control Techniques Ltd

ASCO microfluidic valves can shorten product development cycles

Emerson recently were at Analytica showing customers about the two day sample programme for ASCO Microfluidic valves as well as how they can reduce the cost of reagents in Clinical Diagnostic Applications. Emerson recognises that product development times in the analytical and medical markets need to be as short as possible, so to enable customers to reduce this time sample versions of ASCO microfluidic valves are available within two days of request.

The samples will be hand delivered by Emerson experts who will work with the designer to develop and optimise the process. ASCO micro-fluidic valves combine engineering expertise and modern materials technology to meet the requirements of the manufacturers of the most advanced clinical diagnostic machines.

As well as being able to discuss the two day sample programme, Emerson will be displaying their microfluidic valves used in clinical diagnostic applications. These valves are designed to withstand some of the industry’s harshest chemicals. A key benefit of the ASCO microfluidic isolation valves is their ultra-low dead volume, which reduces the consumption of costly detective reagents. The use of chemically-inert materials makes them suitable for a wide range of applications.

Another key feature of the microfluidic isolation valve range is their extremely low power consumption. The advent of Point of Care testing, means that instrument power budgets are critical to a project design team, something Emerson have taken into account, as they offer some of the lowest power coils in the industry.